Rixubis

Rixubis is a prescription medicine used to prevent and control bleeding in people with hemophilia B, an inherited bleeding disorder. Rixubis belongs to a group of drugs called antihemophilic agents which work by replacing clotting factors required to stop bleeding that are missing in people with hemophilia B.

This medication is available in an injectable form to be given directly into a vein (IV) by a healthcare professional.

Common side effects of Rixubis include a distorted sense of taste and pain in the extremities.

Rixubis is a prescription medication used for:

• control and prevention of bleeding episodes in adults with hemophilia B
• perioperative (before and after surgery) use in adults with hemophilia B
• routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults with hemophilia B

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

• Baxter Healthcare Corporation

Serious side effects have been reported with Rixubis. See the “Rixubis Precautions” section.

Common side effects of Rixubis include distorted taste and pain in the extremities.

This is not a complete list of Rixubis side effects. Ask your doctor or pharmacist for more information.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

No Rixubis drug interactions have been reported, however, you should tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements. Not all drug interactions are known or reported and new drug interactions are continually being reported.

Serious side effects have been reported with Rixubis including:

• Hypersensitivity reactions, including anaphylaxis. Tell your healthcare provider right away if you have some or all of the following symptoms of a hypersensitivity reaction:
  • swelling of the face or lips
  • chest tightness
  • a drop in blood pressure
  • lethargy (sluggishness)
  • nausea
  • vomiting
  • tingling in hands or feet
  • restlessness
  • wheezing
  • difficulty breathing
• Development of proteins that inhibit (stop) the activity of Rixubis. Your healthcare provider will want to monitor for this development.
• Nephrotic syndrome (kidney damage). Tell your healthcare provider right away if you have some or all of the following symptoms of nephrotic syndrome:
  • urine with a foamy appearance
  • poor or decreased appetite
  • swelling around the eyes, feet, and ankles, and in the abdomen (stomach area)
  • weight gain from an increase in fluid in the body
• Complications of blood clot formation. This can be especially dangerous if a blood clot gets stuck in the leg (deep vein thrombosis), the lungs (pulmonary embolism), or if you have a stroke (clotting of a vessel leading to the brain).

 Do not take Rixubis if you:

• have a known hypersensitivity (allergic reaction) to Rixubis or its ingredients
• are allergic to hamsters
• develop disseminated intravascular coagulation (DIC). (DIC is when clotting and bleeding of the blood becomes unbalanced.)
• develop signs of fibrinolysis. (Fibrinolysis is when your blood loses its ability to clot.)

Medications can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods. In the case of Rixubis, there are no specific foods that you must exclude from your diet when receiving this medication.

Before taking Rixubis, tell your doctor about all of your medical conditions. Especially tell your doctor if you:

• have or have had any medical problems
• have any allergies, including allergies to hamsters
• are pregnant or breastfeeding

Tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements.

Tell your doctor if you are pregnant or plan to become pregnant.

The FDA categorizes medications based on safety for use during pregnancy. Five categories - A, B, C, D, and X - are used to classify the possible risks to an unborn baby when a medication is taken during pregnancy.

Rixubis falls into category C. No studies have been done in animals, and there are no well-done studies in pregnant women. Rixubis should be given to a pregnant woman only if clearly needed.

Tell your doctor if you are breastfeeding or plan to breastfeed.

It is not known whether Rixubis crosses into human milk. Because many medications can cross into human milk and because of the possibility for serious adverse reactions in nursing infants with use of this medication, a choice should be made whether to stop nursing or stop the use of this medication. Your doctor and you will decide if the benefits outweigh the risk of using Rixubis.

Take Rixubis exactly as prescribed.

Rixubis is given directly into the bloodstream. Rixubis should be administered as ordered by your healthcare provider. You should be trained on how to do infusions by your healthcare provider or hemophilia treatment center. Many people with hemophilia B learn to infuse their Rixubis by themselves or with the help of a family member.

You may have to have blood tests done after getting Rixubis to be sure that your blood level of factor IX is high enough to clot your blood. Call your healthcare provider right away if your bleeding does not stop after taking Rixubis.

If you miss a dose, take the missed dose as soon as you remember. If it is almost time for the next dose, skip the missed dose and take your next dose at the regular time. Do not take 2doses of Rixubis at the same time.

Take Rixubis exactly as prescribed by your doctor. Follow the directions on your prescription label carefully.

Your healthcare provider will tell you how much Rixubis to use based on your weight, the severity of the factor IX deficiency, the location and extent of bleeding, your clinical condition, age, and recovery of factor IX.

If you take too much Rixubis call your healthcare provider or local Poison Control Center, or seek emergency medical attention right away.

If Rixubis is administered by a healthcare provider in a medical setting, it is unlikely that an overdose will occur. However, if overdose is suspected, seek emergency medical attention.

• Store at refrigerated temperature 2° to 8°C (35 to 46°F). Do not freeze.
• Do not use after the expiration date printed on the carton or vial.
• Do not share Rixubis with other people, even if they have the same symptoms as you do.
• Keep out of reach of children.